Weak yes - which is why we need the study. However, the data we DO have shows a 92% efficacy among people without a second dose. I don't see how this is so weak we should not seriously consider it. 2/983 vs 28/1059. Durability unknown - some ppl go out to 108 days.
-
This Tweet is unavailable.
-
This Tweet is unavailable.
-
-
This Tweet is unavailable.
-
Replying to @K_G_Andersen @michaelmina_lab and
Key word there: "scientific debate." Not "public newspaper debate."
2 replies 0 retweets 4 likes -
This Tweet is unavailable.
-
Replying to @K_G_Andersen @RMCarpiano and
I hear the concern & I think about this a lot. I think the idea something will stay out of the public discussion is not realistic. Do you remember that cloth mask study among healthcare workers? Which found surgical masks were better? (duh) It's had so much public discussion!
1 reply 0 retweets 3 likes -
Replying to @zeynep @K_G_Andersen and
Senators tweeted about it, it went viral, got written up so much (misrepresented). It was a small study in a small journal! The journal ended up having to add an addendum. Barely helped. Anyway. Things can't be walled off. Totally open to how to communicate better!
2 replies 0 retweets 1 like -
Replying to @zeynep @K_G_Andersen and
Research (especially disaster sociology) says accountability and transparency help, but it is a rapidly changing environment so we're all going with some sense of things as we see them, here. And I think detailed explanations are good but always worth thinking about framing.
1 reply 0 retweets 1 like -
Replying to @zeynep @K_G_Andersen and
So I appreciate the feedback! As an addition, data-wise, I am particularly concerned that there won't be sufficient resources to track down and provide booster to older people who clearly are higher risk but more likely to miss it. (HCW will not miss it).
2 replies 0 retweets 4 likes
(So maybe another piece: you may have heard we're trialing single-dose and/or some governor is suggesting a single-dose! Unless you're in that trial, please go get your second dose and/or states please make sure to put resources in follow-up, starting with higher risk). /n
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.